The FDA granted de novo authorization to the first artificial intelligence (AI) program to support breast cancer risk ...

Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced the launch of a new ...

A new artificial intelligence (AI) test can identify which men with prostate cancer will benefit most from the life-extending drug abiraterone, in clinical trial results presented by scientists from ...

Scientists say they have worked out a machine learning method with the ability to provide close to precise survival estimates of patients afflicted ...

Shares of Tempus AI, Inc. (TEM) jumped 17% on Monday morning after the company announced a new liquid biopsy assay intended ...

Johnson & Johnson (NYSE:JNJ) recently announced promising Phase 1 study results for Pasritamig, a novel antibody for advanced ...

CNBC's Angelica Peebles and AstraZeneca CEO Pascal Soriot join 'Squawk Box' to discuss the company's breast cancer drug trial ...

A Step Toward More Accurate and Personalised Breast Cancer Screening ...

Investigators used the Shiny method, which employs artificial intelligence, to indirectly compare the efficacy of novel systemic therapies for urothelial cancer using phase 3 trial data.

Cancer patients are dying after following fake cures peddled online, according to the world’s top doctors. AI and online ...

EVP, Chief Medical Officer and Chief Product Officer, SOPHiA GENETICS | Embrace the transformative power of multimodal ...

The Asia and Oceania Federation of Obstetrics and Gynecology (AOFOG) advocates for the vaccination of both females and males ...